作者: Andre Arizpe , Kelly R. Reveles , Shrina D. Patel , Samuel L. Aitken
DOI: 10.1007/S11908-016-0552-7
关键词: Gram-negative bacteria 、 Piperacillin/tazobactam 、 Carbapenem 、 Cephalosporin 、 Antimicrobial 、 Intensive care medicine 、 Ceftazidime/avibactam 、 Cefepime 、 Microbiology 、 Medicine 、 Pseudomonas aeruginosa
摘要: Resistance to cephalosporins is now common among Gram-negative bacterial infections, including those caused by the Enterobacteriaceae and Pseudomonas aeruginosa, posing a major threat public health. As resistance traditional drugs of choice for these carbapenems, has also become increasingly common, interest in cefepime piperacillin-tazobactam as carbapenem-sparing alternatives increased. Additionally, availability novel β-lactam-β-lactamase inhibitor combinations ceftolozane-tazobactam ceftazidime-avibactam added antimicrobial armamentarium available treat multidrug-resistant infections. Here, we review recent literature on use highlight potential utility antimicrobials.